XIMMUNE AB has a total of 18 patent applications. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are SERONO INTERNAT S A, HOWARD FLOREY INST OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE and HONIGBERG LEE.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 2 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | India | 2 | |
#8 | United Kingdom | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Enzymes | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Schmidtchen Artur | 17 |
#2 | Malmsten Nils Martin | 16 |
#3 | Papareddy Praveen | 16 |
#4 | Kalle Martina | 15 |
#5 | Kasetty Gopinath | 10 |
#6 | Walse Bjoem Ulrik | 6 |
#7 | Walse Bjorn Ulrik | 5 |
#8 | Rydengard Victoria | 3 |
#9 | Rydengaard Victoria | 2 |
#10 | Walse Bjom Ulrik | 2 |
Publication | Filing date | Title |
---|---|---|
GB201204283D0 | Polypeptide derived from helix A of heparin cofactor II | |
WO2011036443A2 | S1 protease c- terminal polypeptides and uses thereof for treating inflammation or coagulation disorders | |
BR112012006502A2 | heparin cofactor ll fragments with anti-inflammatory and anticoagulant activity |